NYSCF Accomplishments & Milestones

The digital program, hosted by Sanjay Gupta, MD, and directed by Scott Ellis, featured numerous celebrity guests and honored 2020 Stem Cell Heroes Frank Gehry, David Rockwell, and Brooke Ellison, PhD.

A study published in Neuron led by Valentina Fossati, PhD, shows that astrocytes – an integral support cell in the brain – created from human stem cells can turn into neuron-killers, opening the door for new understanding and treatment of neurodegenerative diseases.

NYSCF Research Institute scientists and members of the NYSCF Innovator community immediately began developing solutions for those impacted by COVID-19, from better diagnosing the viral infection, to developing treatments and vaccines, to protecting healthcare workers on the front lines.

A new collaboration between the NYSCF Research Institute, Johns Hopkins University School of Medicine, and Bloomberg Philanthropies will advance precision medicine by combining clinical and medical expertise with NYSCF’s unique stem cell technologies.

NYSCF collaboration launches the first 3D models of Parkinson’s disease and multiple sclerosis to the International Space Station on SpaceX cargo flight CRS-18.

NYSCF researchers report in Stem Cell Research that bone-forming cells can be grown without use of animal-derived compounds, paving the way for use in the clinic.

NYSCF’s inaugural Family Stem Cell Day provided local students with the opportunity to speak with researchers and ask questions about stem cells, NYSCF’s work, and what it’s like to be a scientist.

Dedicated the Stavros Niarchos Foundation Scientific Gallery at NYSCF headquarters in Manhattan.

A robust, efficient method for deriving microglia, the immune cells of the brain, from human stem cells published in Stem Cell Reports.

Creation of a new type of stem cell with only one set of chromosomes, haploid stem cells, with colleagues at The Hebrew University of Jerusalem and Columbia University Medical Center reported in Nature.

The NYSCF Global Stem Cell Array highlighted as a faster, more efficient, more reliable, and cost effective method of creating stem cells and derived cell types in Nature Methods.

NYSCF IWISE Working Group publishes “Seven Actionable Strategies for Advancing Women in Science, Engineering, and Medicine,” in Cell Stem Cell.

NYSCF partners with eagle-i Network, of the Harvard Catalyst, creating first-ever open access, searchable stem cell database.

For the first time, scientists successfully derive living iPS cells from frozen Alzheimer’s patient’s brain tissue, reported in Acta Neuropathologica Communications.

Creation of patient-specific, customizable bone to treat disease and injury published in PNAS.

Major breakthrough published in Nature describing a therapy that could prevent the inheritance of mitochondrial diseases.

Awards the NYSCF – Robertson Stem Cell Prize to Dr. Kazutoshi Takahashi for his role in the discovery of induced pluripotent stem cells, a breakthrough that garnered the Nobel Prize for research leader, Dr. Shinya Yamanaka.

Advance in patient-specific stem cells led named the #1 Medical Breakthrough of 77011 by TIME magazine.

Expands research team to begin research in Alzheimer’s disease, bone regeneration, and multiple sclerosis.

Creates NYSCF – Robertson Investigator program for young scientists starting their own laboratories.

TIME and Science magazines cite NYSCF-funded ALS research as the most significant scientific breakthrough of the year.

Susan L. Solomon honored with Women of Excellence Award by Governor David Paterson.

Awards first grants for senior scientists.

Awards first postdoctoral fellowship.

Mayor Bloomberg and Dick Wolf speak at NYSCF’s First Annual Gala for scientists and supporters.

Receives $1.1M of seed funding from two funders.